Loading clinical trials...
Loading clinical trials...
Current diagnostic tools used in pulmonary disease often do not meet the challenges set by the respective pathophysiology. The investigators therefore aimed to evaluate novel or not widely used diagno...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitätsmedizin Mannheim
NCT07579052 · Chronic Obstructive Pulmonary Disease
NCT07572383 · Interstitial Lung Disease, Pulmonary Fibrosis
NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD
NCT05061368 · Chronic Obstructive Pulmonary Disease
NCT05139719 · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Universitätsmedizin Mannheim
Mannheim
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions